Traws Pharma Inc. (TRAW)
NASDAQ · Healthcare
Traws Pharma Inc. EBITDA 2011–2025
Traws Pharma Inc. annual/quarterly ebitda history and growth rate from 2011 to 2025. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Traws Pharma Inc. ebitda for the quarter ending March 31, 2025 was -5.2 M, a 0.12% decrease year-over-year.
- Traws Pharma Inc. ebitda for the twelve months ending March 31, 2025 was -20.7 M, a 7.45% decrease year-over-year.
- Traws Pharma Inc. annual ebitda for 2025 was -17.8 M, a 87.49% decrease from 2024.
- Traws Pharma Inc. annual ebitda for 2024 was -142.4 M, a 601.91% increase from 2023.
- Traws Pharma Inc. annual ebitda for 2023 was -20.3 M, a 3.41% increase from 2022.
- Traws Pharma Inc. annual ebitda for 2022 was -19.6 M.
EBITDA
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Traws Pharma Inc. EBITDA — FAQ
Traws Pharma Inc. (TRAW) ebitda over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see TRAW's ebitda history?
The chart and table above show Traws Pharma Inc.'s ebitda by year and by quarter, including the growth rate.